OtitisDisease1 paperHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 monthsBiology Methods & Protocols·YesterdayComparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatideCohort study of 1,016 peopleTirzepatidePaper
Biology Methods & Protocols·YesterdayComparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatideCohort study of 1,016 peopleTirzepatidePaper